People Living with HIV (PLWH) and Substance Abuse Disorder (SUD): Addressing Barriers to Viral Suppression

This activity is part of a series


Michael Fingerhood, FACP, DFASAM, AAHIVS
Professor of Medicine and Public Health
Johns Hopkins University
Chief, Division of Addiction Medicine
Johns Hopkins Bayview Medical Center
Baltimore, MD
Michael Fingerhood, FACP, DFASAM, AAHIVS

Michael Fingerhood, MD, is a Professor of Medicine and Public Health at Johns Hopkins University, and Chief of the Division of Addiction Medicine at Johns Hopkins Bayview Medical Center. Dr. Fingerhood earned his Bachelor of Arts degree from Johns Hopkins University and his Medical Degree from Albert Einstein College of Medicine. He completed internal medicine training and a chief resident year at Johns Hopkins Bayview Medical Center. The mission of his career has been to promote and improve the provision of medical care to patients with substance use disorder, including the treatment of HIV and hepatitis C, with the development, maintenance and evaluation of innovative programs related to the care of these individuals. Dr. Fingerhood created the Comprehensive Care Practice in 1994, a Ryan White funded primary care practice largely devoted to providing care to individuals with substance use disorder. The practice has been innovative in integrating buprenorphine treatment into the primary care setting for over 650 individuals. He has also co-created novel buprenorphine treatment programs at a community center, at a church and in a mobile van outside the Baltimore detention center. Dr. Fingerhood has received the Health Equity Leadership award from the Baltimore City Health Department and is co-author of the American Society of Addition Medicine (ASAM) Handbook of Addiction Medicine. He was chair of the ASAM Annual Conference Planning Committee from 2014-2020, and currently chairs the ASAM State of the Art Conference and the ASAM Medical Education Council. He has co-authored over 70 research papers and has received NIH research funding continuously over the past 30 years.

Carol Dawson-Rose, RN, PhD, FAAN
James and Marjorie Livingston Endowed Chair in Nursing Excellence
Professor and Chair, Department of Community Health Systems
University of California, San Francisco, School of Nursing
San Francisco, CA
Carol Dawson-Rose, RN, PhD, FAAN

Carol Dawson-Rose, RN, PhD, FAAN, is a Professor and Chair in the Department of Community Health Systems at the University of California, San Francisco (UCSF), School of Nursing. Dr. Dawson-Rose has over 35 years of combined HIV clinical and community-engaged research, primarily focusing on implementing substance use services into programs that support engagement in the HIV care continuum and decreasing substance use stigma. She is the Program Director for the UCSF Center for AIDS Research (CFAR) Substance Use Research Program and a member of the AIDS Research Institute. Dr. Dawson-Rose is co-director of the Next Generation Nurse Scientists Ending the HIV Epidemic, designed to train a diverse cadre of nurse scientists with the research skills needed to lead efforts to end the HIV epidemic. Funded by the National Institute of Nursing Research, this program will build on almost 30 years of cutting-edge HIV research and training in the School of Nursing.

Statement of Need

The co-occurrence of Substance Use Disorder (SUD) for people living with HIV (PLWH) may impact HIV transmission, morbidity, and mortality but is not a contraindication for HIV treatments such as antiretroviral therapy (ART). Guidelines from the U.S. Department of Health and Human Services (HHS) and the Substance Abuse and Mental Health Services Administration (SAMHSA) direct clinicians to screen for potential mental health disorders and provide ART to PLWH and SUD, but education is required for clinicians to understand and meet the treatment challenges for these individuals and choose between the various ART treatment options to meet their unique needs.

This CMEO BriefCase entitled, People Living with HIV (PLWH) and Substance Abuse Disorder (SUD): Addressing Barriers to Viral Suppression, will discuss a specific case of an individual who must simultaneously face the challenges of living with HIV as well as having a SUD. Expert faculty will address mental health screening and different ART treatment options for HIV given the difficulties and unique barriers faced by patients with a comorbid condition of SUD.

Learning Objective

Implement strategies to overcome barriers to viral suppression in PLWH and co-occurring SUD.

Financial Support

This program has been supported by an independent educational grant from Gilead Sciences, Inc.

Target Audience

Primary care practitioners, physician associates (PAs), nurse practitioners (NPs), nurses, and pharmacists specializing in HIV.

Credit Information

Jointly Accredited Provider

In support of improving patient care, CME Outfitters, LLC, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Interprofessional (IPCE) 0.75

This activity was planned by and for the healthcare team, and learners will receive 0.75 Interprofessional Continuing Education (IPCE) Credit for learning and change.

Physicians (ACCME) 0.75

CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. CME Outfitters, LLC, designates this enduring activity for a maximum of .75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants (AAPA): 0.75

CME Outfitters, LLC, has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.75 AAPA Category 1 CME credits. Approval is valid until expiration date listed above. PAs should only claim credit commensurate with the extent of their participation.

Nurses (ANCC) 0.75

This activity is designated for 0.75 contact hour. Nurse practitioners can apply for AMA PRA Category 1 Credit(s)™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit(s)™ from Jointly Accredited Organizations. Nurse practitioners can also apply for credit through their state boards.

Note for California Nurses

This continuing nursing education activity was approved by the California Board of Registered Nursing. CME Outfitters, LLC’s provider number is CEP15510.

Pharmacists (ACPE) 0.75

This application-based activity is approved for 0.75 contact hour (0.075 CEUs) of continuing pharmacy credit.
Activity UAN: JA0007185-0000-23-086-H01-P


Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Royal College MOC

Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

MIPS Improvement Activity

Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process.

Dr. Fingerhood reports no financial relationships to disclose.

Dr. Dawson-Rose reports no financial relationships to disclose.

Disclosures were obtained from the CME Outfitters, LLC staff; no disclosures to report:

  • Joshua Caballero, PharmD, BCPP, FCCP (peer reviewer)
  • Mary Gleason, PhD (planning committee)
  • Kellie Busby, PharmD (planning committee)
  • Susan H. Yarbrough, CHCP (planning committee)
  • Sandra Caballero, PharmD (planning committee)
  • Sharon Tordoff (planning committee)

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Obtaining Credit

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit our Privacy & Confidentiality page.

Questions about this activity?

Call us at 877.CME.PROS (877.263.7767).


People Living with HIV (PLWH) and Substance Abuse Disorder (SUD): Addressing Barriers to Viral Suppression
Event Date: 09/07/2023 at 4:00 am EST